Nona Biosciences and MedUni Vienna Collaborate on Infectious Diseases
CAMBRIDGE, Massachusetts, July 23, 2026 Nona Biosciences has announced a strategic research collaboration with the Medical University of Vienna...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CAMBRIDGE, Massachusetts, July 23, 2026 Nona Biosciences has announced a strategic research collaboration with the Medical University of Vienna...
TOKYO, Japan, July 23, 2026 The Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately JPY...
DELFT, The Netherlands, June 30, 2026 AdJane, a clinical-stage vaccine platform company, has announced the publication of first-in-human Phase...
Newtown, Pennsylvania | February 19, 2026 — Traws Pharma announced completion of its clinical analysis evaluating ratutrelvir, an investigational...
